Re: BETonMACE Enrollment
in response to
by
posted on
Feb 11, 2019 09:05AM
** Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Cardiovascular Outcomes Trial ** BETonMACE Trial is Fully Enrolled and Expected to be Completed H1 2019 https://clinicaltrials.gov/ct2/show/NCT02586155